Artiva Biotherapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ARTV

Comments

Artiva Biotherapeutics Inc Earnings Estimates

ARTVNASDAQ

Trade with Public

$5.01

-0.15-2.91%

At close: Mar 27, 5:00 PM EST

$5.11

0.102.05%

After Hours: 5:49 PM EST

Overview NewsEarningsAnalyst Ratings Insider Trades Short Interest Stock Report

Artiva Biotherapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ARTV

Artiva Biotherapeutics (ARTV) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $-0.86 and quarterly revenue of N/A.

In the most recent quarter (Q4), Artiva Biotherapeutics reported EPS of $-0.84, missing estimates of $-0.83 by 0.01%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Artiva Biotherapeutics has missed EPS estimates in 7 consecutive quarters.

Over the last 4 quarters, Artiva Biotherapeutics has averaged an EPS surprise of 0.10% and a revenue surprise of 0.00%.

Earnings Date

May 7

EPS Estimate

$-0.860

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–

Artiva Biotherapeutics Earnings History

Analyze the earnings history of Artiva Biotherapeutics using advanced sorting and filters.

Loading calendar...

Artiva Biotherapeutics (ARTV) Earnings Per Share

The chart below shows Artiva Biotherapeutics's reported EPS compared to analyst estimates over recent quarters.

Artiva Biotherapeutics (ARTV) Revenue

The chart below shows Artiva Biotherapeutics's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Artiva Biotherapeutics (NASDAQ:ARTV) reporting earnings?

Artiva Biotherapeutics (ARTV) is scheduled to report earnings on May 7, 2026. The last reported earnings were for reported on March 10, 2026 for Q4.

What were the latest earnings per share (EPS) for Artiva Biotherapeutics (NASDAQ:ARTV)?

The Actual EPS was $-0.84, which missed the estimate of $-0.83.

What were Artiva Biotherapeutics’s (NASDAQ:ARTV) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

Kalaris Therapeutics Inc

Inovio Pharmaceuticals Inc

NASDAQ:INO

$1.57

-2.42%

Fate Therapeutics Inc

NASDAQ:FATE

$1.22

4.27%

Sangamo Therapeutics Inc

Artiva Biotherapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ARTV

Artiva Biotherapeutics (ARTV) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $-0.86 and quarterly revenue of N/A.

In the most recent quarter (Q4), Artiva Biotherapeutics reported EPS of $-0.84, missing estimates of $-0.83 by 0.01%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Artiva Biotherapeutics has missed EPS estimates in 7 consecutive quarters.

Over the last 4 quarters, Artiva Biotherapeutics has averaged an EPS surprise of 0.10% and a revenue surprise of 0.00%.

Earnings Date

May 7

EPS Estimate

$-0.860

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–